Casey DeSantis Cancer Research Program
Forecasted
The Casey DeSantis Cancer Research Program funds innovative, high-impact cancer research in Florida, prioritizing projects with rapid, measurable clinical, translational, or prevention outcomes within one year.
Funder: Florida Casey DeSantis Cancer Research Program
Due Dates (Anticipated): September 2026 (portal opens) | October 2026 (Period 1 deadline) | November 2026 (Period 2 deadline) | January 2027 (Period 3 / final deadline)
Funding Amounts: Up to $2,000,000 per award; one-year project period; total program funding ~$70M (FY 2026-27, projected)
Summary: Supports high-impact, innovative cancer research and care projects at Florida-based institutions with rapid (12-month) clinical, translational, or prevention outcomes.
Key Information: All dates are anticipated/projected; eligibility restricted to Florida-based healthcare and research entities; only one application per PI per cycle.
Description
The Casey DeSantis Cancer Research Program, administered by the Florida Department of Health, aims to elevate the quality and competitiveness of cancer care across Florida by funding innovative, high-impact cancer research and care projects. The program encourages rapid, measurable advances in cancer treatment, prevention, and patient outcomes within a one-year project period. Funding supports a broad spectrum of projects, including translational research, clinical trials, nutrition-based prevention, generic drug repurposing, and implementation science, with an emphasis on collaboration and statewide impact. Projects must demonstrate immediate applicability, potential for clinical translation, and measurable deliverables that benefit Floridians.
